Moderna Gains FDA Authorization for Its Coronavirus Vaccine
The Food and Drug Administration authorized a second coronavirus vaccine on Friday. The emergency use authorization (EUA) for Moderna's (NASDAQ: MRNA) mRNA-1273 comes just a day after the agency's advisory committee unanimously recommend authorizing the vaccine and a week after Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) received an EUA for their coronavirus vaccine, BNT162b2.
Moderna plans to deliver approximately 20 million doses of the vaccine by the end of the month.
Image source: Getty Images.
Source Fool.com
